# Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer

> **NCT00692289** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1510 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00692289
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 1510 (ACTUAL)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692289, "Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00692289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*